Coronary interventions One-year outcomes after Absorb bioresorbable vascular scaffold implantation in routine clinical practice Capranzano P, Longo G, Tamburino Cl, Gargiulo G, Ohno Y, Francaviglia B, La Manna A, Di Salvo M-E, Grasso C, Sgroi C, Capodanno D, Tamburino C June 10, 2016 | 10.4244/EIJV12I2A28
Interventions for valvular disease Impact of chronic kidney disease on outcomes after percutaneous mitral valve repair with the MitraClip system: insights from the GRASP registry Ohno Y, Attizzani G, Capodanno D, Barbanti M, Cannata S, Dipasqua F, Imme S, Ministeri M, Caggegi A, Pistritto A, Chiaranda M, Ronsivalle G, Giaquinta S, Mangiafico S, Scandura S, Capranzano P, Tamburino C, Grasso C April 8, 2016 | 10.4244/EIJV11I14A316
Comparison of suture-based vascular closure devices in transfemoral transcatheter aortic valve implantation Barbanti M, Capranzano P, Ohno Y, Gulino S, Sgroi C, Imme S, Tamburino Cl, Cannata S, Patane M, Di Stefano D, Todaro D, Di Simone E, Deste W, Gargiulo G, Capodanno D, Grasso C, Tamburino C October 20, 2015 | 10.4244/EIJV11I6A137
New issue Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue (Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right)) December 6, 2019
JAA This week's JAA's: EXTREME Study, Stent Optimization, Trifurcation disease and more December 3, 2019
Trials Book New update! Discover 17 new trials (The Trials book is supported by Biotronik) October 29, 2019
Editorial 2019 – A leap year for valvular heart disease (Course directors PCR London Valves 2019) November 15, 2019